265 related articles for article (PubMed ID: 32235767)
1. Pirfenidone Inhibits Cell Proliferation and Collagen I Production of Primary Human Intestinal Fibroblasts.
Cui Y; Zhang M; Leng C; Blokzijl T; Jansen BH; Dijkstra G; Faber KN
Cells; 2020 Mar; 9(3):. PubMed ID: 32235767
[TBL] [Abstract][Full Text] [Related]
2. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-β1/Smad/CTGF signaling pathway.
Sun YW; Zhang YY; Ke XJ; Wu XJ; Chen ZF; Chi P
Eur J Pharmacol; 2018 Mar; 822():199-206. PubMed ID: 29374548
[TBL] [Abstract][Full Text] [Related]
3. Pirfenidone suppresses TGF‑β1‑induced human intestinal fibroblasts activities by regulating proliferation and apoptosis via the inhibition of the Smad and PI3K/AKT signaling pathway.
Sun Y; Zhang Y; Chi P
Mol Med Rep; 2018 Oct; 18(4):3907-3913. PubMed ID: 30152848
[TBL] [Abstract][Full Text] [Related]
4. Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro.
Stahnke T; Kowtharapu BS; Stachs O; Schmitz KP; Wurm J; Wree A; Guthoff RF; Hovakimyan M
PLoS One; 2017; 12(2):e0172592. PubMed ID: 28231275
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells.
Hisatomi K; Mukae H; Sakamoto N; Ishimatsu Y; Kakugawa T; Hara S; Fujita H; Nakamichi S; Oku H; Urata Y; Kubota H; Nagata K; Kohno S
BMC Pulm Med; 2012 Jun; 12():24. PubMed ID: 22694981
[TBL] [Abstract][Full Text] [Related]
6. Effects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon's fibroblasts in vitro.
Lin X; Yu M; Wu K; Yuan H; Zhong H
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3763-70. PubMed ID: 19264889
[TBL] [Abstract][Full Text] [Related]
7. Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19.
Choi K; Lee K; Ryu SW; Im M; Kook KH; Choi C
Mol Vis; 2012; 18():1010-20. PubMed ID: 22550395
[TBL] [Abstract][Full Text] [Related]
8. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
[TBL] [Abstract][Full Text] [Related]
9. Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts.
Nakayama S; Mukae H; Sakamoto N; Kakugawa T; Yoshioka S; Soda H; Oku H; Urata Y; Kondo T; Kubota H; Nagata K; Kohno S
Life Sci; 2008 Jan; 82(3-4):210-7. PubMed ID: 18093617
[TBL] [Abstract][Full Text] [Related]
10. Pirfenidone suppresses keloid fibroblast-embedded collagen gel contraction.
Saito M; Yamazaki M; Maeda T; Matsumura H; Setoguchi Y; Tsuboi R
Arch Dermatol Res; 2012 Apr; 304(3):217-22. PubMed ID: 22033529
[TBL] [Abstract][Full Text] [Related]
11. Pirfenidone inhibits transforming growth factor β1-induced extracellular matrix production in nasal polyp-derived fibroblasts.
Shin JM; Park JH; Park IH; Lee HM
Am J Rhinol Allergy; 2015; 29(6):408-13. PubMed ID: 26637578
[TBL] [Abstract][Full Text] [Related]
12. Effect of Pirfenidone on TGF-β1-Induced Myofibroblast Differentiation and Extracellular Matrix Homeostasis of Human Orbital Fibroblasts in Graves' Ophthalmopathy.
Wu SB; Hou TY; Kau HC; Tsai CC
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680057
[TBL] [Abstract][Full Text] [Related]
13. Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1.
Jin J; Togo S; Kadoya K; Tulafu M; Namba Y; Iwai M; Watanabe J; Nagahama K; Okabe T; Hidayat M; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Sasaki S; Tominaga S; Takahashi K
Respir Res; 2019 Jun; 20(1):119. PubMed ID: 31185973
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus abrogates TGF-β1-induced type I collagen production in normal human fibroblasts through suppressing p38MAPK signalling pathway: implications on treatment of chronic atopic dermatitis lesions.
Lan CC; Fang AH; Wu PH; Wu CS
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):204-15. PubMed ID: 23301526
[TBL] [Abstract][Full Text] [Related]
15. [Antifibrotic effect of pirfenidone on orbital fibroblasts in patients with thyroid-associated ophthalmopathy and its mechanisms].
Li DD; Liu Y; Yuan RR; Yu T; Yang B; Pang WY
Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):185-190. PubMed ID: 30803176
[No Abstract] [Full Text] [Related]
16. Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells.
Molina-Molina M; Machahua-Huamani C; Vicens-Zygmunt V; Llatjós R; Escobar I; Sala-Llinas E; Luburich-Hernaiz P; Dorca J; Montes-Worboys A
BMC Pulm Med; 2018 Apr; 18(1):63. PubMed ID: 29703175
[TBL] [Abstract][Full Text] [Related]
17. Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production.
Di Sario A; Bendia E; Svegliati Baroni G; Ridolfi F; Casini A; Ceni E; Saccomanno S; Marzioni M; Trozzi L; Sterpetti P; Taffetani S; Benedetti A
J Hepatol; 2002 Nov; 37(5):584-91. PubMed ID: 12399223
[TBL] [Abstract][Full Text] [Related]
18. The
Tao Y; Chen Q; Zhao C; Yang X; Cun Q; Yang W; Zhang Y; Zhu Y; Zhong H
Int J Med Sci; 2020; 17(6):734-744. PubMed ID: 32218695
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin inhibits transforming growth factor β1-induced fibrogenesis in primary human lung fibroblasts.
Gao Y; Xu X; Ding K; Liang Y; Jiang D; Dai H
Yonsei Med J; 2013 Mar; 54(2):437-44. PubMed ID: 23364979
[TBL] [Abstract][Full Text] [Related]
20. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
